About Timm Crowder
Form D filings for Aerami Therapeutics from 2020 to 2021 list Timm Crowder as executive officer.
Timm Crowder first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Timm Crowder in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Timm Crowder works with at each company, as listed on that company's latest Form D.
Aerami Therapeutics Holdings, Inc. · Form D/A, Nov 4, 2021
AW
Anne Whitaker
Director
JP
John Patton
Director
BW
Bill Welch
Director
AS
Adam Stern
Director
KB
K Bell
Executive officer
ST
Steve Thornton
Chief Executive Officer and director
DH
Darlene Deptula-Hicks
Director